Wordt geladen...
'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?
Aspirin is one of the 'cornerstone' drugs in our current management of cardiovascular disorders. However, despite the prescription of aspirin recurrent vascular events still occur in 10–20% of patients. These, data together with the observations of diminished antiaggregatory response to as...
Bewaard in:
Hoofdauteurs: | , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
BioMed Central
2008
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2535592/ https://ncbi.nlm.nih.gov/pubmed/18759979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-47 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|